# text.div
COVID-19 Vaccines

A mixed enumeration of concepts from WHO, SNOMED CT (International & UK Editions), ICD-11 , CVX, NZMT, AIR and CPT

Id | covid-19-vaccines
Url | https://terminz.azurewebsites.net/fhir/ValueSet/covid-19-vaccines
Version | 20220731
Publisher | HL7 New Zealand
Copyright | WHO Collaborating Centre for Drug Statistics Methodology | SNOMED Clinical Terms® (SNOMED CT®) is copyright of the International Health Terminology Standards Development Organisation (IHTSDO) (trading as SNOMED International). | World Health Organization | © 2023+ New Zealand Crown Copyright | Copyright © 2018+ Australian Digital Health Agency - All rights reserved. | CPT copyright 2021 American Medical Association. All rights reserved. | Unified Medical Language System® (UMLS®)
Status | Draft
Status Date | 2024-04-29
Experimental? | True
Expansion Total | 112
Expansion Offset/Count | 0/-1

System | Code | Display
http://www.whocc.no/atc | J07BX03 | covid-19 vaccines
http://snomed.info/sct | 28531000087107 | COVID-19 vaccine
http://snomed.info/sct | 1119305005 | SARS-CoV-2 antigen vaccine
http://snomed.info/sct | 1157024006 | Inactivated whole SARS-CoV-2 antigen vaccine
http://snomed.info/sct | 1162643001 | SARS-CoV-2 recombinant spike protein antigen vaccine
http://snomed.info/sct | 30141000087107 | COVID-19 virus-like particle antigen vaccine
http://snomed.info/sct | 1119349007 | SARS-CoV-2 mRNA vaccine
http://snomed.info/sct | 1187593009 | SARS-CoV-2 DNA plasmid encoding spike protein vaccine
http://snomed.info/sct | 29061000087103 | COVID-19 non-replicating viral vector vaccine
http://id.who.int/icd/entity | 894585096 | COVID-19 vaccine
http://id.who.int/icd/entity | 1104808441 | COVID-19 vaccine, inactivated virus
http://id.who.int/icd/entity | 993066376 | COVID-19 vaccine, live attenuated virus
http://id.who.int/icd/entity | 264142908 | COVID-19 vaccine, non-replicating viral vector
http://id.who.int/icd/entity | 877986394 | COVID-19 vaccine, replicating viral vector
http://id.who.int/icd/entity | 1368305645 | COVID-19 vaccine, virus protein subunit
http://id.who.int/icd/entity | 729916172 | COVID-19 vaccine, virus like particle (VLP)
http://id.who.int/icd/entity | 1316179031 | COVID-19 vaccine, DNA based
http://id.who.int/icd/entity | 873941688 | COVID-19 vaccine, RNA based
http://id.who.int/icd/release/11/mms | XM68M6 | COVID-19 vaccine
http://id.who.int/icd/release/11/mms | XM1NL1 | COVID-19 vaccine, inactivated virus
http://id.who.int/icd/release/11/mms | XM5DF6 | COVID-19 vaccine, live attenuated virus
http://id.who.int/icd/release/11/mms | XM9QW8 | COVID-19 vaccine, non-replicating viral vector
http://id.who.int/icd/release/11/mms | XM0CX4 | COVID-19 vaccine, replicating viral vector
http://id.who.int/icd/release/11/mms | XM5JC5 | COVID-19 vaccine, virus protein subunit
http://id.who.int/icd/release/11/mms | XM1J92 | COVID-19 vaccine, virus like particle (VLP)
http://id.who.int/icd/release/11/mms | XM6AT1 | COVID-19 vaccine, DNA based
http://id.who.int/icd/release/11/mms | XM0GQ8 | COVID-19 vaccine, RNA based
http://hl7.org/fhir/sid/cvx | 207 | COVID-19, mRNA, LNP-S, PF, 100 mcg/0.5 mL dose
http://hl7.org/fhir/sid/cvx | 208 | COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose
http://hl7.org/fhir/sid/cvx | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL
http://hl7.org/fhir/sid/cvx | 211 | COVID-19 vaccine, Subunit, rS-nanoparticle+Matrix-M1 Adjuvant, PF, 0.5 mL
http://hl7.org/fhir/sid/cvx | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL
http://hl7.org/fhir/sid/cvx | 213 | SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED
http://hl7.org/fhir/sid/cvx | 217 | COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose, tris-sucrose
http://hl7.org/fhir/sid/cvx | 218 | COVID-19, mRNA, LNP-S, PF, 10 mcg/0.2 mL dose, tris-sucrose
http://hl7.org/fhir/sid/cvx | 219 | COVID-19, mRNA, LNP-S, PF, 3 mcg/0.2 mL dose, tris-sucrose
http://hl7.org/fhir/sid/cvx | 221 | COVID-19, subunit, rS-nanoparticle+Matrix-M1 Adjuvant, PF, 0.5 mL
http://hl7.org/fhir/sid/cvx | 227 | COVID-19, subunit, rS-nanoparticle+Matrix-M1 Adjuvant, PF, 0.5 mL
http://hl7.org/fhir/sid/cvx | 228 | COVID-19, mRNA, LNP-S, PF, pediatric 25 mcg/0.25 mL dose
http://hl7.org/fhir/sid/cvx | 229 | COVID-19, mRNA, LNP-S, bivalent booster, PF, 50 mcg/0.5 mL or 25mcg/0.25 mL dose
http://hl7.org/fhir/sid/cvx | 300 | COVID-19, mRNA, LNP-S, bivalent booster, PF, 30 mcg/0.3 mL dose
http://hl7.org/fhir/sid/cvx | 301 | COVID-19, mRNA, LNP-S, bivalent booster, PF, 10 mcg/0.2 mL dose
http://hl7.org/fhir/sid/cvx | 308 | COVID-19, mRNA, LNP-S, PF, tris-sucrose, 3 mcg/0.3 mL
http://hl7.org/fhir/sid/cvx | 309 | 309 COVID-19, mRNA, LNP-S, PF, tris-sucrose, 30 mcg/0.3 mL
http://hl7.org/fhir/sid/cvx | 310 | COVID-19, mRNA, LNP-S, PF, tris-sucrose, 10 mcg/0.3 mL
http://hl7.org/fhir/sid/cvx | 311 | COVID-19, mRNA, LNP-S, PF, 25 mcg/0.25 mL
http://hl7.org/fhir/sid/cvx | 312 | COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL
http://hl7.org/fhir/sid/cvx | 313 | COVID-19, subunit, rS-nanoparticle, adjuvanted, PF, 5 mcg/0.5 mL
http://hl7.org/fhir/sid/cvx | 500 | SARS-COV-2 COVID-19 Non-US Vaccine, Specific Product Unknown
http://hl7.org/fhir/sid/cvx | 501 | SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (QAZCOVID-IN)
http://hl7.org/fhir/sid/cvx | 502 | SARS COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (COVAXIN)
http://hl7.org/fhir/sid/cvx | 503 | SARS-COV-2 COVID-19 Live Attenuated Virus Non-US Vaccine Product (COVIVAC)
http://hl7.org/fhir/sid/cvx | 504 | SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (Sputnik Light)
http://hl7.org/fhir/sid/cvx | 505 | SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (Sputnik V)
http://hl7.org/fhir/sid/cvx | 506 | SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (CanSino Biological Inc./Beijing Institute of Biotechnology
http://hl7.org/fhir/sid/cvx | 507 | SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Anhui Zhifei Longcom Biopharmaceutical + Institute of Microbiology, Chinese Academy of Sciences)
http://hl7.org/fhir/sid/cvx | 508 | SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Jiangsu Province Centers for Disease Control and Prevention)
http://hl7.org/fhir/sid/cvx | 509 | SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (EpiVacCorona)
http://hl7.org/fhir/sid/cvx | 510 | SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (BIBP, Sinopharm)
http://hl7.org/fhir/sid/cvx | 511 | SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (CoronaVac, Sinovac)
http://hl7.org/fhir/sid/cvx | 512 | SARS-COV-2 COVID-19 VLP Non-US Vaccine (Medicago, Covifenz)
http://hl7.org/fhir/sid/cvx | 513 | SARS-COV-2 COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom, Zifivax)
http://hl7.org/fhir/sid/cvx | 514 | SARS-COV-2 COVID-19 DNA Non-US Vaccine (Zydus Cadila, ZyCoV-D)
http://hl7.org/fhir/sid/cvx | 515 | SARS-COV-2 COVID-19 PS Non-US Vaccine (Medigen, MVC-COV1901)
http://hl7.org/fhir/sid/cvx | 516 | COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC)
http://hl7.org/fhir/sid/cvx | 517 | SARS-COV-2 COVID-19 PS Non-US Vaccine (Biological E Limited, Corbevax)
http://hl7.org/fhir/sid/cvx | 518 | COVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva)
http://hl7.org/fhir/sid/cvx | 519 | COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna
http://hl7.org/fhir/sid/cvx | 520 | COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product, Pfizer-BioNTech
http://nzmt.org.nz | 47362371000116107 | severe acute respiratory syndrome coronavirus 2 (COVID-19) vaccine (medicinal product)
http://nzmt.org.nz | 47407721000116102 | Comirnaty (Pfizer-BioNTech) (trade product)
http://nzmt.org.nz | 47407751000116105 | Comirnaty (Pfizer-BioNTech) (tozinameran (BNT162b2) (mRNA) 225 microgram/0.45 mL (30 microgram/0.3 mL administered dose)) COVID-19 mRNA vaccine injection: concentrated, vial (trade product unit of use)
http://nzmt.org.nz | 47547081000116102 | Comirnaty (Pfizer-BioNTech) (tozinameran (BNT162b2) (mRNA) 130 microgram/1.3 mL (10 microgram/0.2 mL administered dose)) COVID-19 mRNA vaccine injection: concentrated, vial (trade product unit of use)
http://nzmt.org.nz | 47572291000116106 | Comirnaty (Pfizer-BioNTech) (tozinameran (BNT162b2) (mRNA) 225 microgram/2.25 mL (30 microgram/0.3 mL administered dose)) (grey) COVID-19 mRNA vaccine injection: concentrated, vial (trade product unit of use)
http://nzmt.org.nz | 47485531000116100 | Convidecia (CanSino) (trade product)
http://nzmt.org.nz | 47483691000116104 | CoronaVac (Sinovac) (trade product)
http://nzmt.org.nz | 47483221000116100 | CoVaxin (Bharat) (trade product)
http://nzmt.org.nz | 47362041000116101 | COVID-19 Vaccine AstraZeneca (trade product)
http://nzmt.org.nz | 47362071000116105 | COVID-19 Vaccine AstraZeneca (ChAdOx1-S virus 50 billion viral particles/0.5 mL) COVID-19 vaccine, injection: solution, vial (trade product unit of use)
http://nzmt.org.nz | 47485961000116102 | COVID-19 vaccine Sinopharm (trade product)
http://nzmt.org.nz | 47482631000116107 | Covishield (trade product)
http://nzmt.org.nz | 47346751000116107 | Janssen COVID-19 (trade product)
http://nzmt.org.nz | 47409001000116102 | Spikevax (Moderna) (trade product)
http://nzmt.org.nz | 47486531000116105 | Sputnik V (Gamaleya) (trade product)
http://nzmt.org.nz | 47482831000116108 | Vaxzevria (trade product)
http://www.ama-assn.org/go/cpt | 91300 | Pfizer-BioNTech COVID-19 Vaccine
http://www.ama-assn.org/go/cpt | 91301 | Moderna COVID-19 Vaccine
http://www.ama-assn.org/go/cpt | 91302 | AstraZeneca COVID-19 Vaccine
http://www.ama-assn.org/go/cpt | 91303 | Janssen COVID-19 Vaccine
http://www.ama-assn.org/go/cpt | 91304 | Novavax COVID-19 Vaccine
https://www.humanservices.gov.au/organisations/health-professionals/enablers/air-vaccine-code-formats | COMIRN | Pfizer Comirnaty
https://www.humanservices.gov.au/organisations/health-professionals/enablers/air-vaccine-code-formats | COVAST | COVID-19 Vaccine AstraZeneca
http://snomed.info/sct | 1525021000168100 | COVID-19 mRNA vaccine
http://snomed.info/sct | 1527271000168101 | COVID-19 Vaccine (AstraZeneca)
http://snomed.info/sct | 1525011000168107 | COVID-19 BNT162b2 Vaccine (Pfizer-BioNTech)
http://snomed.info/sct | 39115611000001103 | COVID-19 mRNA Vaccine Pfizer-BioNTech BNT162b2 30micrograms/0.3ml dose concentrate for suspension for injection multidose vials (Pfizer Ltd)
http://snomed.info/sct | 39114911000001105 | COVID-19 Vaccine AstraZeneca (ChAdOx1 S [recombinant]) 5x10,000,000,000 viral particles/0.5ml dose solution for injection multidose vials (AstraZeneca)
http://snomed.info/sct | 39230211000001104 | Astute 100,000,000,000 (100 billion) viral particles/0.5ml dose solution for injection multidose vials (Janssen-Cilag Ltd)
http://snomed.info/sct | 39326911000001101 | COVID-19 mRNA (nucleoside modified) Vaccine Moderna 0.1mg/0.5mL dose dispersion for injection multidose vials (Moderna, Inc)
http://snomed.info/sct | 39373511000001104 | COVID-19 Vaccine Valneva (inactivated adjuvanted whole virus) 40antigen units/0.5mL dose suspension for injection multidose vials (Valneva UK Ltd)
http://snomed.info/sct | 28581000087106 | PFIZER-BIONTECH COVID-19 mRNA
http://snomed.info/sct | 28571000087109 | MODERNA COVID-19 mRNA-1273
http://snomed.info/sct | 28761000087108 | ASTRAZENECA COVID-19 AZC
http://snomed.info/sct | 28961000087105 | COVISHIELD COVID-19 VP
http://snomed.info/sct | 28951000087107 | JANSSEN COVID-19 Jan
http://www.nlm.nih.gov/research/umls/rxnorm | 2470234 | SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 0.2 MG/ML Injectable Suspension
http://www.nlm.nih.gov/research/umls/rxnorm | 2468235 | SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 0.1 MG/ML Injectable Suspension
http://www.nlm.nih.gov/research/umls/rxnorm | 2479835 | ARS-COV-2 (COVID-19) vaccine, vector - Ad26 100000000000 UNT/ML Injectable Suspension
https://ec.europa.eu/health/documents/community-register/html/ | EU/1/20/1528 | Comirnaty
https://ec.europa.eu/health/documents/community-register/html/ | EU/1/20/1507 | COVID-19 Vaccine Moderna
https://ec.europa.eu/health/documents/community-register/html/ | EU/1/21/1529 | Vaxzevria
https://ec.europa.eu/health/documents/community-register/html/ | EU/1/20/1525 | COVID-19 Vaccine Janssen

# description
A mixed enumeration of concepts from WHO, SNOMED CT (International & UK Editions), ICD-11 , CVX, NZMT, AIR and CPT

# purpose
To be used for DEMONSTRATION PURPOSES ONLY.

# copyright
WHO Collaborating Centre for Drug Statistics Methodology | SNOMED Clinical Terms® (SNOMED CT®) is copyright of the International Health Terminology Standards Development Organisation (IHTSDO) (trading as SNOMED International). | World Health Organization | © 2023+ New Zealand Crown Copyright | Copyright © 2018+ Australian Digital Health Agency - All rights reserved.  | CPT copyright 2021 American Medical Association. All rights reserved. | Unified Medical Language System® (UMLS®)

# expansion.contains[].display
Inactivated whole SARS-CoV-2 antigen vaccine

# expansion.contains[].display
SARS-CoV-2 recombinant spike protein antigen vaccine

# expansion.contains[].display
COVID-19 virus-like particle antigen vaccine

# expansion.contains[].display
SARS-CoV-2 DNA plasmid encoding spike protein vaccine

# expansion.contains[].display
COVID-19 non-replicating viral vector vaccine

# expansion.contains[].display
COVID-19 vaccine, non-replicating viral vector

# expansion.contains[].display
COVID-19 vaccine, replicating viral vector

# expansion.contains[].display
COVID-19 vaccine, virus like particle (VLP)

# expansion.contains[].display
COVID-19 vaccine, non-replicating viral vector

# expansion.contains[].display
COVID-19 vaccine, replicating viral vector

# expansion.contains[].display
COVID-19 vaccine, virus like particle (VLP)

# expansion.contains[].display
COVID-19, mRNA, LNP-S, PF, 100 mcg/0.5 mL dose

# expansion.contains[].display
COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose

# expansion.contains[].display
COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL

# expansion.contains[].display
COVID-19 vaccine, Subunit, rS-nanoparticle+Matrix-M1 Adjuvant, PF, 0.5 mL

# expansion.contains[].display
COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL

# expansion.contains[].display
COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose, tris-sucrose

# expansion.contains[].display
COVID-19, mRNA, LNP-S, PF, 10 mcg/0.2 mL dose, tris-sucrose

# expansion.contains[].display
COVID-19, mRNA, LNP-S, PF, 3 mcg/0.2 mL dose, tris-sucrose

# expansion.contains[].display
COVID-19, subunit, rS-nanoparticle+Matrix-M1 Adjuvant, PF, 0.5 mL

# expansion.contains[].display
COVID-19, subunit, rS-nanoparticle+Matrix-M1 Adjuvant, PF, 0.5 mL

# expansion.contains[].display
COVID-19, mRNA, LNP-S, PF, pediatric 25 mcg/0.25 mL dose

# expansion.contains[].display
COVID-19, mRNA, LNP-S, bivalent booster, PF, 50 mcg/0.5 mL or 25mcg/0.25 mL dose

# expansion.contains[].display
COVID-19, mRNA, LNP-S, bivalent booster, PF, 30 mcg/0.3 mL dose

# expansion.contains[].display
COVID-19, mRNA, LNP-S, bivalent booster, PF, 10 mcg/0.2 mL dose

# expansion.contains[].display
COVID-19, mRNA, LNP-S, PF, tris-sucrose, 3 mcg/0.3 mL

# expansion.contains[].display
309 COVID-19, mRNA, LNP-S, PF, tris-sucrose, 30 mcg/0.3 mL

# expansion.contains[].display
COVID-19, mRNA, LNP-S, PF, tris-sucrose, 10 mcg/0.3 mL

# expansion.contains[].display
COVID-19, subunit, rS-nanoparticle, adjuvanted, PF, 5 mcg/0.5 mL

# expansion.contains[].display
SARS-COV-2 COVID-19 Non-US Vaccine, Specific Product Unknown

# expansion.contains[].display
SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (QAZCOVID-IN)

# expansion.contains[].display
SARS COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (COVAXIN)

# expansion.contains[].display
SARS-COV-2 COVID-19 Live Attenuated Virus Non-US Vaccine Product (COVIVAC)

# expansion.contains[].display
SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (Sputnik Light)

# expansion.contains[].display
SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (Sputnik V)

# expansion.contains[].display
SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (CanSino Biological Inc./Beijing Institute of Biotechnology

# expansion.contains[].display
SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Anhui Zhifei Longcom Biopharmaceutical + Institute of Microbiology, Chinese Academy of Sciences)

# expansion.contains[].display
SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Jiangsu Province Centers for Disease Control and Prevention)

# expansion.contains[].display
SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (EpiVacCorona)

# expansion.contains[].display
SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (BIBP, Sinopharm)

# expansion.contains[].display
SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (CoronaVac, Sinovac)

# expansion.contains[].display
SARS-COV-2 COVID-19 VLP Non-US Vaccine (Medicago, Covifenz)

# expansion.contains[].display
SARS-COV-2 COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom, Zifivax)

# expansion.contains[].display
SARS-COV-2 COVID-19 DNA Non-US Vaccine (Zydus Cadila, ZyCoV-D)

# expansion.contains[].display
SARS-COV-2 COVID-19 PS Non-US Vaccine (Medigen, MVC-COV1901)

# expansion.contains[].display
COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC)

# expansion.contains[].display
SARS-COV-2 COVID-19 PS Non-US Vaccine (Biological E Limited, Corbevax)

# expansion.contains[].display
COVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva)

# expansion.contains[].display
COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna

# expansion.contains[].display
COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product, Pfizer-BioNTech

# expansion.contains[].display
severe acute respiratory syndrome coronavirus 2 (COVID-19) vaccine (medicinal product)

# expansion.contains[].display
Comirnaty (Pfizer-BioNTech) (tozinameran (BNT162b2) (mRNA) 225 microgram/0.45 mL (30 microgram/0.3 mL administered dose)) COVID-19 mRNA vaccine injection: concentrated, vial (trade product unit of use)

# expansion.contains[].display
Comirnaty (Pfizer-BioNTech) (tozinameran (BNT162b2) (mRNA) 130 microgram/1.3 mL (10 microgram/0.2 mL administered dose)) COVID-19 mRNA vaccine injection: concentrated, vial (trade product unit of use)

# expansion.contains[].display
Comirnaty (Pfizer-BioNTech) (tozinameran (BNT162b2) (mRNA) 225 microgram/2.25 mL (30 microgram/0.3 mL administered dose)) (grey) COVID-19 mRNA vaccine injection: concentrated, vial (trade product unit of use)

# expansion.contains[].display
COVID-19 Vaccine AstraZeneca (trade product)

# expansion.contains[].display
COVID-19 Vaccine AstraZeneca (ChAdOx1-S virus 50 billion viral particles/0.5 mL) COVID-19 vaccine, injection: solution, vial (trade product unit of use)

# expansion.contains[].display
COVID-19 vaccine Sinopharm (trade product)

# expansion.contains[].display
COVID-19 mRNA Vaccine Pfizer-BioNTech BNT162b2 30micrograms/0.3ml dose concentrate for suspension for injection multidose vials (Pfizer Ltd)

# expansion.contains[].display
COVID-19 Vaccine AstraZeneca (ChAdOx1 S [recombinant]) 5x10,000,000,000 viral particles/0.5ml dose solution for injection multidose vials (AstraZeneca)

# expansion.contains[].display
Astute 100,000,000,000 (100 billion) viral particles/0.5ml dose solution for injection multidose vials (Janssen-Cilag Ltd)

# expansion.contains[].display
COVID-19 mRNA (nucleoside modified) Vaccine Moderna 0.1mg/0.5mL dose dispersion for injection multidose vials (Moderna, Inc)

# expansion.contains[].display
COVID-19 Vaccine Valneva (inactivated adjuvanted whole virus) 40antigen units/0.5mL dose suspension for injection multidose vials (Valneva UK Ltd)

# expansion.contains[].display
SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 0.2 MG/ML Injectable Suspension

# expansion.contains[].display
SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 0.1 MG/ML Injectable Suspension

# expansion.contains[].display
ARS-COV-2 (COVID-19) vaccine, vector - Ad26 100000000000 UNT/ML Injectable Suspension